Benefits of new FDA safety determination go beyond expanding patients’ options
Patient-level meta-analysis of ILLUMENATE trials finds no increased mortality with Stellarex DCB
Risk attenuates as recovered data are added
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement